Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Seven Convicted For Selling Tainted Capsules In Zhejiang

This article was originally published in PharmAsia News

Executive Summary

Seven people were convicted by a Zhejiang court for selling tainted capsules as drugs and handed down jail sentences ranging from 10 months to 11 years.

Seven people were convicted by a Zhejiang court for selling tainted capsules as drugs and handed down jail sentences ranging from 10 months to 11 years. They were also fined RMB 30,000 to RMB 1.22 million. Media reported that some people had swallowed pharma capsules made of leather waste and contained excessive metal in April 2012. Subsequent official investigations discovered six provinces were affected with 13 contaminated batches of drugs from nine companies. (Click Here For More - Chinese Language)

Seven People Sentenced, One with 11 Years’ Imprisonment In Tainted Capsule Incident In Zhejiang- news365.com.cn (2/8/2013)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC083479

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel